FRS3 and hematopoietic and lymphoid system neoplasm: The waterfall and box plots demonstrate that inhibition of FRS3 in blood cancer and METTL1 in liver cancer leads to a significant decrease in the viability of TP53 and CCND1-mutated cell lines, respectively, compared with pWT cell lines (Fig 4B and C).